Skip to main content
logo
Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.390
-0.070 (-4.79%)
At close: May 15, 2026, 4:00 PM EDT
1.419
+0.029 (2.12%)
After-hours: May 15, 2026, 7:58 PM EDT

Ocugen Revenue

Ocugen had revenue of $1.53M in the quarter ending March 31, 2026, with 3.51% growth. This brings the company's revenue in the last twelve months to $4.47M, down -1.26% year-over-year. In the year 2025, Ocugen had annual revenue of $4.41M with 8.83% growth.

Revenue (ttm)
$4.47M
Revenue Growth
-1.26%
P/S Ratio
105.38
Revenue / Employee
$38,491
Employees
116
Market Cap
470.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.41M358.00K8.83%
Dec 31, 20244.06M-1.98M-32.82%
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 202043.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20138.00K-18.00K-69.23%
Dec 31, 201226.00K-97.00K-78.86%
Dec 31, 2011123.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
4D Molecular Therapeutics88.24M
Fulcrum Therapeutics80.00M
Assembly Biosciences71.10M
Prelude Therapeutics16.72M
Ovid Therapeutics7.12M
Upstream Bio3.32M
Shattuck Labs1.00M
Neurogene925.00K
Revenue Rankings

OCGN News

More News